Intraarticular administration of dexamethasone after mesenchymal stem cells implantation does not improve significantly the treatment of preestablished full-thickness chondral defect in a rabbit model

Simple item page
dc.contributor.authorEspinosa, Maximiliano
dc.contributor.authorVaisman, Alex
dc.contributor.authorNazal, Nicolas
dc.contributor.authorFigueroa, David
dc.contributor.authorGallegos, Marcela
dc.contributor.authorConget, Paulette
dc.date.accessioned2017-04-07T15:50:15Z
dc.date.available2017-04-07T15:50:15Z
dc.date.issued2013
dc.descriptionCentro de Medicina Regenerativa
dc.description.abstractObjective: The aim of this study was to evaluate the contribution to hyaline cartilage regeneration of dexamethasone intraarticular administration after autologous mesenchymal stem cells (MSCs) implantation into a preestablished knee full-thickness chondral defect. Design: Full-thickness chondral defects of 4.5 × 4.5 mm2 were surgically made in both medial femoral condyles of adult male New Zealand rabbits. Two weeks later, autologous ex vivo expanded bone marrow–derived MSCs were embedded in hyaluronic acid and implanted into the chondral defects. Immediately and every week after the intervention, dexamethasone 0.25 mg/kg was intraarticularly administered (MSC/dexa-treated group). Six weeks after MSC transplantation, the animals were euthanized and condyles were characterized molecularly according to aggrecan, collagen type II, and collagen type I gene expression (quantitative reverse transcriptase-polymerase chain reaction) and histologically (hematoxylin–eosin staining). Data of MSC/dexa-treated condyles were compared with untreated, dexa-treated, MSCtreated, or normal unlesioned condyles. Results: The ratio between collagen type II expression versus collagen type I expression in MSC/dexa-treated condyles was higher than one, even though the group mean value was not statistically different from that of untreated defects. Histological changes were observed between MSC/dexa-treated and untreated defects mainly in surface regularity and in hyaline matrix abundance. However, International Cartilage Repair Society score analysis did not support robust differences between those groups. Conclusion: Intraarticular administration of dexamethasone after autologous MSC implantation into a preestablished full-thickness chondral defect does not contribute significantly to the regeneration of a tissue with molecular and histological characteristics identical to hyaline cartilage.
dc.format.extent9
dc.identifier.citationCartilage. 2013 Apr; 4(2): 144–152
dc.identifier.urihttp://hdl.handle.net/11447/1114
dc.identifier.urihttp://dx.doi.org/10.1177/1947603512472696
dc.language.isoen_US
dc.publisherSage Publications
dc.subjecthyaline cartilage regeneration
dc.subjectfull-thickness chondral defect
dc.subjectmesenchymal stem cells
dc.subjectdexamethasone
dc.titleIntraarticular administration of dexamethasone after mesenchymal stem cells implantation does not improve significantly the treatment of preestablished full-thickness chondral defect in a rabbit model
dc.typeArtículo

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Intraarticular Administration of Dexamethasone after Mesenchymal Stem Cells Implantation Does Not Improve Significantly the Treatment of Preestablished Full-Thickness Chondral Defect in a Rabbit Model.pdf
Size:
489.08 KB
Format:
Adobe Portable Document Format
Description:
Texto completo
Download

Collections

Artículos Medicina y Ciencias de la Salud

Implementado por OpenGeek Services